SCHEMBL2554915

SCHEMBL2554915

C=CN1CCCC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23666153 0.93
SCHEMBL5688867 0.81
SCHEMBL2975726 0.75
SCHEMBL2754245 0.75
SCHEMBL19524515 0.73 CA1 (0.34)
SCHEMBL17798808 0.70
SCHEMBL6381448 0.70
SCHEMBL10613627 0.70
SCHEMBL17320217 0.70
SCHEMBL28074257 0.70 CA12 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2008233-A None JP disclosed
US-11807704-B2 Functionalized polymer, process for preparing and rubber compositions containing the functionalized polymer BRIDGESTONE CORPORATION (JP) 2023-11-07 US disclosed
US-20180171053-A1 Functionalized Polymer, Process For Preparing And Rubber Compositions Containing The Functionalized Polymer BRIDGESTONE CORPORATION (JP) 2018-06-21 US disclosed
EP-2346909-B1 POLYMERS DERIVED FROM N-VINYL FORMAMIDE, VINYL AMIDES OR ACRYLAMIDES, AND REACTION SOLVENT, AND THE USES THEREOF ISP INVESTMENTS INC (US) 2018-05-16 EP disclosed
US-9587135-B2 Aqueous dispersion of composite particles DOW GLOBAL TECHNOLOGIES LLC (US) 2017-03-07 US disclosed
US-20160317456-A1 PHARMACEUTICAL COMPOSITIONS PURDUE PHARMA LP (US) 2016-11-03 US disclosed
CN-102307983-B The method being obtained concentration polyphenol extract by stirring technique BRASSERIES KRONENBOURG (FR) 2016-06-01 CN disclosed
US-8748626-B2 Oxazole and thiazole compounds as KSP inhibitors NOVARTIS AG (CH) 2014-06-10 US disclosed
US-20130224186-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS KSP INHIBITORS NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2013-08-29 US disclosed
EP-2558452-A2 OXAZOLE AND THIAZOLE COMPOUNDS AS KSP INHIBITORS Novartis AG (CH) 2013-02-20 EP disclosed
US-20050266072-A1 Pharmaceutical compositions EURO-CELTIQUE S.A. (LU) 2005-12-01 US disclosed
EP-1542658-A1 PHARMACEUTICAL COMPOSITIONS Euro-Celtique S.A. (LU) 2005-06-22 EP disclosed
WO-2005007135-A1 PHARMACEUTICAL COMPOSITIONS EURO-CELTIQUE S.A. (LU) 2005-01-27 WO disclosed
US-6479564-B1 Isocyanate-based hardenable preparations BASF AKTIENGESELLSCHAFT (DE) 2002-11-12 US disclosed
EP-1141068-B1 ISOCYANATE-BASED CURABLE PREPARATIONS BASF AG (DE) 2002-07-31 EP disclosed
US-5807576-A PARTICULATE POLYPEPTIDE SUPPORT MATRIX; GERIATRICS, PEDIATRICS THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1998-09-15 US disclosed
US-5635210-A FORMING A POROUS PARTICULATE SUPPORT MATRIX; DISPERSING A DRUG; ADDING ADJUVANTS, E.G., FLAVORS, BINDERS, EFFERVESCENT AGENTS; FORMING A TABLET, APPLYING A COATING; EASILY SWALLOWED THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1997-06-03 US disclosed
US-5595761-A POLYPEPTIDE SUPPORT, GELATIN AND BULKING AGENT THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1997-01-21 US disclosed
US-5587180-A COMPRISING A NON-HYDROLYZED AND A HYDROLYZED GELATIN WITH A BULKING AGENT; EVAPORATION OF SOLVENT AND VOLATILIZING AGENT FROM DROPS IN HEATED DRYING CHAMBER; EXPANSION THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 1996-12-24 US disclosed
JP-H028233-A RUBBER COMPOSITION NIPPON ZEON CO LTD 1990-01-11 JP disclosed